PRISM BioLab Co.,Ltd announced that it has raised ¥1,500 million in a round of funding on January 24, 2024. The transaction included participation from new investors Eli Lilly and Company and santec Holdings Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8,170 JPY | +4.34% | +6.38% | +163.97% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
8,170 JPY | +4.34% | +6.38% | 587M | ||
883.3 USD | +1.85% | +5.50% | 795B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.97% | 587M | |
+9.79% | 106B | |
-3.18% | 30.35B | |
+3.08% | 20.44B | |
-11.67% | 18.7B | |
-12.24% | 16.24B | |
+13.02% | 15.88B | |
+5.12% | 12.86B | |
+17.56% | 12.82B | |
+12.89% | 8.51B |
- Stock Market
- Equities
- 6777 Stock
- News santec Holdings Corporation
- PRISM BioLab Co.,Ltd announced that it has received ¥1.5 billion in funding from santec Holdings Corporation, Eli Lilly and Company